Clinical Trials Browser

INDUSTRY × Advanced Cancer × Valganciclovir × Clear all

NCT06302140 2025-01-20

A Mass Balance Study of [14C]-Nanatinostat and Relative Bioavailability Study of Nanatinostat in Patients With Advanced Cancers

Phase 1 Terminated

Advanced Cancer